Liver disease & HCC

At CGMH Linkou in Taiwan, workflow optimisation increased lab efficiency, allowing addition of PIVKA-II testing

At CGMH Linkou in Taiwan, workflow optimisation increased lab efficiency, allowing addition of PIVKA-II testing

  Chang Gung Memorial Hospital Linkou (CGMH Linkou) is one of Taiwan’s largest hospitals, serving millions of patients annually. It also operates one of the country’s busiest clinical labs. The hospital plans to expand this lab in the coming years, but in the meantime, it’s constantly working to improve performance and increase offerings in the […]

At CGMH Linkou in Taiwan, workflow optimisation increased lab efficiency, allowing addition of PIVKA-II testing Read More »

Dr John Ward on expanding HCV testing to achieve elimination goals

Dr John Ward on expanding HCV testing to achieve elimination goals

As Director of the Coalition for Global Hepatitis Elimination of the Task Force for Global Health, Dr John Ward has deep experience in supporting hepatitis elimination strategies around the world. In this presentation at RED 2023, he focuses on the challenges around hepatitis C (HCV) elimination. This includes discussion of model programmes from around the

Dr John Ward on expanding HCV testing to achieve elimination goals Read More »

Pakistan’s national HCV elimination programme: insights from Dr Huma Qureshi

Pakistan’s national HCV elimination programme: insights from Dr Huma Qureshi

This article is part of a series on hepatitis C (HCV) elimination in Pakistan and other high-risk countries around the world. Other articles in this series cover the Pakistani provinces of Punjab, KPK and Sindh. Scroll to the bottom of the article for the full list. In 2019, Pakistan announced a countrywide programme to scale

Pakistan’s national HCV elimination programme: insights from Dr Huma Qureshi Read More »

HCV elimination in Sindh: insights from Prof Muhammad Sadik Memon and Dr Zaigham Abbas

HCV elimination in Sindh: insights from Prof Muhammad Sadik Memon and Dr Zaigham Abbas

This article is part of a series on hepatitis C virus (HCV) elimination in Pakistan and other high-risk countries around the world. Other articles in this series cover the Pakistani provinces of Punjab and KPK. Scroll to the bottom of the article for the full list. HBV and HCV are major public health threats in

HCV elimination in Sindh: insights from Prof Muhammad Sadik Memon and Dr Zaigham Abbas Read More »

Liver disease and patient advocacy in Taiwan: Q&A with Prof Yang Pei-Ming

Liver disease and patient advocacy in Taiwan: Q&A with Prof Yang Pei-Ming

Liver disease is a serious public health issue in Taiwan. In a population of over 23 million, roughly 15%–20% of adults are hepatitis B viral (HBV) carriers, and 2%–5% are infected with hepatitis C virus (HCV) [1]. To address these challenges, Taiwan’s healthcare community has shown a strong commitment to fighting viral hepatitis, improving outcomes

Liver disease and patient advocacy in Taiwan: Q&A with Prof Yang Pei-Ming Read More »

Scroll to Top